APH logo

Amphenol (APH) Cash and cash equivalents

annual cash & cash equivalents:

$3.32B+$1.84B(+124.88%)
December 31, 2024

Summary

  • As of today (May 29, 2025), APH annual cash & cash equivalents is $3.32 billion, with the most recent change of +$1.84 billion (+124.88%) on December 31, 2024.
  • During the last 3 years, APH annual cash & cash equivalents has risen by +$2.12 billion (+177.09%).
  • APH annual cash & cash equivalents is now at all-time high.

Performance

APH Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPHbalance sheet metrics

quarterly cash & cash equivalents:

$1.66B-$1.66B(-50.04%)
March 31, 2025

Summary

  • As of today (May 29, 2025), APH quarterly cash & cash equivalents is $1.66 billion, with the most recent change of -$1.66 billion (-50.04%) on March 31, 2025.
  • Over the past year, APH quarterly cash & cash equivalents has dropped by -$199.90 million (-10.76%).
  • APH quarterly cash & cash equivalents is now -50.04% below its all-time high of $3.32 billion, reached on December 31, 2024.

Performance

APH quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPHbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

APH Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+124.9%-10.8%
3 y3 years+177.1%+32.8%
5 y5 years+272.2%-30.1%

APH Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+177.1%-50.0%+39.4%
5 y5-yearat high+272.2%-50.0%+39.4%
alltimeall timeat high>+9999.0%-50.0%>+9999.0%

APH Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$1.66B(-50.0%)
Dec 2024
$3.32B(+124.9%)
$3.32B(+112.2%)
Sep 2024
-
$1.56B(+24.8%)
Jun 2024
-
$1.25B(-32.6%)
Mar 2024
-
$1.86B(+25.9%)
Dec 2023
$1.48B(+7.4%)
$1.48B(-0.4%)
Sep 2023
-
$1.48B(+11.8%)
Jun 2023
-
$1.33B(-4.7%)
Mar 2023
-
$1.39B(+1.3%)
Dec 2022
$1.37B(+14.7%)
$1.37B(+15.5%)
Sep 2022
-
$1.19B(-2.2%)
Jun 2022
-
$1.22B(-2.6%)
Mar 2022
-
$1.25B(+4.2%)
Dec 2021
$1.20B(-29.7%)
$1.20B(-5.6%)
Sep 2021
-
$1.27B(+4.9%)
Jun 2021
-
$1.21B(-48.0%)
Mar 2021
-
$2.33B(+36.8%)
Dec 2020
$1.70B(+91.0%)
$1.70B(+19.8%)
Sep 2020
-
$1.42B(+10.3%)
Jun 2020
-
$1.29B(-45.7%)
Mar 2020
-
$2.37B(+166.2%)
Dec 2019
$891.20M(-30.3%)
$891.20M(-8.1%)
Sep 2019
-
$969.30M(-1.3%)
Jun 2019
-
$982.30M(+1.3%)
Mar 2019
-
$969.70M(-24.2%)
Dec 2018
$1.28B(-25.6%)
$1.28B(+28.1%)
Sep 2018
-
$998.30M(+3.5%)
Jun 2018
-
$964.40M(-3.6%)
Mar 2018
-
$1.00B(-41.8%)
Dec 2017
$1.72B(+66.2%)
$1.72B(+18.4%)
Sep 2017
-
$1.45B(+10.3%)
Jun 2017
-
$1.32B(+6.0%)
Mar 2017
-
$1.24B(+20.1%)
Dec 2016
$1.03B(-40.4%)
$1.03B(+21.2%)
Sep 2016
-
$853.60M(+7.5%)
Jun 2016
-
$794.00M(+15.6%)
Mar 2016
-
$687.00M(-60.5%)
Dec 2015
$1.74B(+79.3%)
$1.74B(+10.3%)
Sep 2015
-
$1.58B(+26.8%)
Jun 2015
-
$1.24B(+28.1%)
Mar 2015
-
$969.90M(+0.1%)
Dec 2014
$968.90M(+9.3%)
$968.90M(+11.0%)
Sep 2014
-
$873.00M(-19.2%)
Jun 2014
-
$1.08B(+5.5%)
Mar 2014
-
$1.02B(+15.4%)
Dec 2013
$886.80M(+28.4%)
$886.80M(-0.3%)
Sep 2013
-
$889.37M(+22.9%)
Jun 2013
-
$723.66M(-1.5%)
Mar 2013
-
$734.99M(+6.4%)
Dec 2012
$690.85M(+34.1%)
$690.85M(-4.8%)
Sep 2012
-
$725.55M(+12.3%)
Jun 2012
-
$646.01M(+4.0%)
Mar 2012
-
$620.98M(+20.6%)
Dec 2011
$515.09M(-2.1%)
$515.09M(-25.4%)
Sep 2011
-
$690.18M(+12.9%)
Jun 2011
-
$611.21M(+3.1%)
Mar 2011
-
$593.00M(+12.8%)
Dec 2010
$525.89M(+36.7%)
$525.89M(+9.4%)
Sep 2010
-
$480.53M(+10.0%)
Jun 2010
-
$436.68M(+1.1%)
Mar 2010
-
$431.72M(+12.2%)
Dec 2009
$384.61M(+78.9%)
$384.61M(+25.0%)
Sep 2009
-
$307.57M(+39.3%)
Jun 2009
-
$220.76M(+46.7%)
Mar 2009
-
$150.52M(-30.0%)
Dec 2008
$214.99M
$214.99M(-6.8%)
Sep 2008
-
$230.74M(+22.2%)
DateAnnualQuarterly
Jun 2008
-
$188.76M(+4.8%)
Mar 2008
-
$180.16M(-1.9%)
Dec 2007
$183.64M(+147.7%)
$183.64M(+11.6%)
Sep 2007
-
$164.59M(+48.7%)
Jun 2007
-
$110.67M(+30.1%)
Mar 2007
-
$85.09M(+14.8%)
Dec 2006
$74.14M(+91.7%)
$74.14M(+18.1%)
Sep 2006
-
$62.76M(+36.7%)
Jun 2006
-
$45.92M(+23.1%)
Mar 2006
-
$37.30M(-3.5%)
Dec 2005
$38.67M(+28.2%)
$38.67M(+1.6%)
Sep 2005
-
$38.06M(+49.5%)
Jun 2005
-
$25.46M(-3.0%)
Mar 2005
-
$26.26M(-13.0%)
Dec 2004
$30.17M(+28.2%)
$30.17M(+34.0%)
Sep 2004
-
$22.52M(+20.9%)
Jun 2004
-
$18.63M(-34.4%)
Mar 2004
-
$28.40M(+20.7%)
Dec 2003
$23.53M(+13.9%)
$23.53M(+38.6%)
Sep 2003
-
$16.98M(-23.9%)
Jun 2003
-
$22.33M(-30.5%)
Mar 2003
-
$32.14M(+55.6%)
Dec 2002
$20.66M(-26.2%)
$20.66M(-18.0%)
Sep 2002
-
$25.20M(+31.0%)
Jun 2002
-
$19.24M(-28.2%)
Mar 2002
-
$26.80M(-4.2%)
Dec 2001
$27.98M(+13.8%)
$27.98M(+23.0%)
Sep 2001
-
$22.75M(+32.8%)
Jun 2001
-
$17.14M(-22.0%)
Mar 2001
-
$21.97M(-10.6%)
Dec 2000
$24.59M(+90.6%)
$24.59M(+41.3%)
Sep 2000
-
$17.40M(+21.2%)
Jun 2000
-
$14.36M(+14.3%)
Mar 2000
-
$12.56M(-2.6%)
Dec 1999
$12.90M(+316.1%)
$12.90M(+43.3%)
Sep 1999
-
$9.00M(+13.9%)
Jun 1999
-
$7.90M(+107.9%)
Mar 1999
-
$3.80M(+22.6%)
Dec 1998
$3.10M(-34.0%)
$3.10M(+34.8%)
Sep 1998
-
$2.30M(-20.7%)
Jun 1998
-
$2.90M(-52.5%)
Mar 1998
-
$6.10M(+29.8%)
Dec 1997
$4.70M(+17.5%)
$4.70M(-39.0%)
Sep 1997
-
$7.70M(-23.8%)
Jun 1997
-
$10.10M(+48.5%)
Mar 1997
-
$6.80M(+70.0%)
Dec 1996
$4.00M(-66.7%)
$4.00M(+37.9%)
Sep 1996
-
$2.90M(-86.1%)
Jun 1996
-
$20.90M(-26.1%)
Mar 1996
-
$28.30M(+135.8%)
Dec 1995
$12.00M(+160.9%)
$12.00M(+233.3%)
Sep 1995
-
$3.60M(-44.6%)
Jun 1995
-
$6.50M(+38.3%)
Mar 1995
-
$4.70M(+2.2%)
Dec 1994
$4.60M(+58.6%)
$4.60M(-2.1%)
Sep 1994
-
$4.70M(+161.1%)
Jun 1994
-
$1.80M(-50.0%)
Mar 1994
-
$3.60M(+24.1%)
Dec 1993
$2.90M(-44.2%)
$2.90M(-31.0%)
Sep 1993
-
$4.20M(-12.5%)
Jun 1993
-
$4.80M(+33.3%)
Mar 1993
-
$3.60M(-30.8%)
Dec 1992
$5.20M(-27.8%)
$5.20M(-10.3%)
Sep 1992
-
$5.80M(+48.7%)
Jun 1992
-
$3.90M(+69.6%)
Mar 1992
-
$2.30M(-68.1%)
Dec 1991
$7.20M(+22.0%)
$7.20M(+22.0%)
Dec 1990
$5.90M
$5.90M

FAQ

  • What is Amphenol annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Amphenol?
  • What is Amphenol annual cash & cash equivalents year-on-year change?
  • What is Amphenol quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Amphenol?
  • What is Amphenol quarterly cash & cash equivalents year-on-year change?

What is Amphenol annual cash & cash equivalents?

The current annual cash & cash equivalents of APH is $3.32B

What is the all time high annual cash & cash equivalents for Amphenol?

Amphenol all-time high annual cash & cash equivalents is $3.32B

What is Amphenol annual cash & cash equivalents year-on-year change?

Over the past year, APH annual cash & cash equivalents has changed by +$1.84B (+124.88%)

What is Amphenol quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of APH is $1.66B

What is the all time high quarterly cash & cash equivalents for Amphenol?

Amphenol all-time high quarterly cash & cash equivalents is $3.32B

What is Amphenol quarterly cash & cash equivalents year-on-year change?

Over the past year, APH quarterly cash & cash equivalents has changed by -$199.90M (-10.76%)
On this page